Most Poles prefer the Pfizer vaccine
Image by Shutterstock.com
If Poles were allowed to choose their COVID-19 vaccine, 41.7% would opt for the Pfizer vaccine, while only 4.8% would select AstraZeneca, a survey by the SW Research pollster has shown, according to a report by news agency PAP.
Some 25% of the respondents said they were not planning to inoculate themselves against the coronavirus. 9% preferred the Moderna vaccine and 8.7% the Johnson & Johnson vaccine.
Nearly 11% said they didn't mind which vaccine they received.
The Pfizer vaccine was more frequently chosen by women (46%) than men (36%), and predominantly by people over the age of 50. The Moderna vaccine was most frequently indicated by high-bracket earners (15%). Most low-bracket earners chose the AstraZeneca vaccine (9%).
SW Research ran the survey on May 11-12 on a random sample of 800 internet users above the age of 18.
ÁKK Sells HUF 50 bln of Bonds at Auction, Over Plan
Hungary to Address Future of Cohesion Policy During EU Presi...
2/3 of Hungarians Have Basic Expectation of Home Office
Time Out Market to Open in Budapest Next Year
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
